The Effects of Lemborexant on the Ability to Sleep During Daytime

Summary

This study aim to evaluate whether a dose of 5 mg of lemborexant, as compared to a placebo, may improve daytime recovery sleep, without producing lingering sleepiness during wakefulness, using a 3-day simulated night shift protocol in the lab under constant monitoring.

Timeline

Start

2024-01-11

Primary completion

2026-03-31

Completion

2026-03-31

Outcome

Outcome not reported

Stopped (Enrollment): “In agreement with all parties, the project was closed on March 31 due to recruitment challenges.”

Drugs

Indications